Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company is headquartered in Englewood, Colorado and currently employs 6 full-time employees. The company went IPO on 2011-05-19. The firm is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.
Ampio Pharmaceuticals Inc'in kazanç kalite puanı B+/49.115738'dir. Puan, karlılık, büyüme, nakit üretimi ve sermaye tahsisi ile kaldıraç olmak üzere dört boyuta dayanır.
Ampio Pharmaceuticals Inc kazançlarını ne zaman rapor eder?
Ampio Pharmaceuticals Inc'in bir sonraki kazanç raporu 2025-06-23'te bekleniyor